OS Therapies CEO on its latest clinical advancements
CEO & Founder Conversations
•
4m 43s
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
Up Next in CEO & Founder Conversations
-
Public Co-CEO + Co-Founder on how AI ...
Leif Abraham, Co-CEO & Co-Founder of Public, joined Judy Shaw on #NYSEFloorTalk to discuss how AI is shaping investor access to research, trends driving market interest, and how Public.com is navigating opportunities in stocks, bonds, and crypto. 📈🚀
-
Grove Collaborative CEO on its missio...
Jeff Yurcisin, CEO of Grove Collaborative, joined #NYSEFloorTalk to discuss the company’s mission to eliminate single-use plastics, its shift back to DTC, and what’s next for sustainable consumer products in 2025. #ICRConference2025
-
a.k.a. Brands CEO on how it's brands ...
Ciaran Long, CEO & CFO of a.k.a. Brands, joined Judy Shaw on #NYSEFloorTalk to discuss how brands like Princess Polly and Culture Kings are standing out in a competitive market, the company’s omnichannel growth strategy, and what’s next for 2025. 👗🛍️ #ICRConference2025
